References
- Greenberg LH, Momary H. Audiotoxicity and nephrotoxicity due to orally administered neomycin. JAMA 1965; 194: 837–8
- Elkington SC, Floch MH, Conn HO. Lactulose in the treatment of chronic portal-systemic encephalopathy: a double-blind clinical trial. N Engl J Med 1969; 281: 408–12
- Vince A, Killingley M, Wrong O. Effect of lactulose on ammonia production in a fecal incubation system. Gastroenterology 1978; 74: 544–9
- Rake MO, Flute PT, Pannell G. Intravascular coagulation in acute hepatic necrosis. Lancet 1970; 1: 533–7
- Rake MO, Flute PT, Shilkin KB, et al. Early and intensive therapy of intravascular coagulation in acute liver failure. Lancet 1971; 2: 1215–8
- Macdougall BR, Bailey RJ, Williams R. H2-receptor antagonists and antacids in the prevention of acute gastrointestinal hemorrhage in fulminant hepatic failure: two controlled trials. Lancet 1977; 1: 617–9
- Ware AJ, D'Agostino AN, Combes B. Cerebral edema: a major complication of massive hepatic necrosis. Gastroenterology 1971; 61: 877–84
- Fishman R. Comment. In: Annotated abstracts of a workshop on fulminant hepatic failure. Am J Gastroenterol 1978; 69: 361
- Trewby PN, Chase RA, Davis M, el al. The role of the false neurotransmitter octopamine in the hypotension of fulminant hepatic failure. Clin Sci Mol Med 1977; 52: 305–10
- Conn HO. A rational approach to the hepatorenal syndrome. Gastroenterology 1973; 65: 321–40
- Stanley NN, Salisbury BG, McHenry LC Jr. et al. Effect of liver failure on the response of ventilation and cerebral circulation to carbon dioxide in man and in the goat. Clin Sci Mol Med 1975; 49: 157–69
- Stanley NN. Comment. In: Annotated abstracts,8 pp 357–8
- Scotto J, Opolon P, Etévé J, et al. Liver biopsy and prognosis in acute liver failure. Gut 1973; 140: 927–33
- Bloomer JR, Waldmann TA, McIntire KR, et al. Serum alpha-fetoprotein in patients with massive hepatic necrosis. Gastroenterology 1977; 72: 479–92
- Karvountzis GG, Redeker AG, Peters RL. Long term follow-up studies of patients surviving fulminant viral hepatitis. Gastroenterology 1974; 67: 870–7
- Fischer JE, Rosen HM, Ebeid AM, et al. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 1976; 80: 77–91
- Zieve L, Doizaki WM, Zieve J. Synergism between mercaptans and ammonia or fatty acids in the production of coma: a possible role for mercaptans in the pathogenesis of hepatic coma. J Lab Clin Med 1974; 83: 16–28
- Fischer JE, Baldessarini RJ. Pathogenesis and therapy of hepatic coma. In: Popper H, Schaffner F, eds. Progress in liver diseases. Vol 5. New York: Grune & Stratton, 1976: 363–97
- Fürst P, Zimmerman L, Bergström L. Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol 1976; 3: 178–88